Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.

Item
http://www.wikidata.org/entity/Q33416342
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors.Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer.Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.Potential impact of mTOR inhibitors on cervical squamous cell carcinoma: A systematic review.Potential Therapeutic Targets in Uterine Sarcomas.Targeting protein kinases to reverse multidrug resistance in sarcoma.Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs.Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study.Taming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions.
P2860

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.

Item
http://www.wikidata.org/entity/Q33416342
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase I study and preclinical ...... s with advanced solid tumours.
@ast
Phase I study and preclinical ...... s with advanced solid tumours.
@en
type
label
Phase I study and preclinical ...... s with advanced solid tumours.
@ast
Phase I study and preclinical ...... s with advanced solid tumours.
@en
prefLabel
Phase I study and preclinical ...... s with advanced solid tumours.
@ast
Phase I study and preclinical ...... s with advanced solid tumours.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Phase I study and preclinical ...... s with advanced solid tumours.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P932